Eli Lilly and Co/ US5324571083 /
5/21/2024 10:10:00 PM | Chg. +19.99 | Volume | Bid1:12:32 PM | Ask1:12:32 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
803.17USD | +2.55% | 4.33 mill. Turnover: 1.86 bill. |
805.00Bid Size: 200 | 806.87Ask Size: 100 | 763.34 bill.USD | 0.58% | 138.00 |
GlobeNewswire
5/16
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire
5/16
Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire
5/13
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/13
Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire
5/8
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
5/8
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...
GlobeNewswire
5/1
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
4/29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
4/26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
4/22
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
4/22
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
4/15
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...